Gapping up
In reaction to news:
In reaction to news:
- X +X% (Nippon Steel Corporation (NPSCY) to acquire U. S. Steel for $55.00/share in cash)
- NIO +10.8% (announces $2.2 billion strategic equity investment from CYVN Holdings)
- FREY +9.6% (announced that the DOE has invited the Company to submit the Part II loan application under the DOE Title 17 program for FREYR's Giga America project; receives shareholder approval for redomicile from Luxembourg to the U.S.)
- PGTI +8.7% (Masonite (DOOR) announced a definitive agreement under which Masonite will acquire PGTI for a combination of cash and Masonite shares with a total transaction value of $3.0 bln)
- VOD +7.1% (The iliad Group has submitted to Vodafone Group a proposal for the merger of iliad Italia and Vodafone Italia)
- ILMN +7.0% (announced that the company will divest GRAIL)
- BLNK +5.7% (Citadel Advisors LLC disclosed 0.4% passive stake)
- CAMT +3.7% (receives order of 25 systems from a leading Outsourced Semiconductor Assembly and Test for various Advanced Packaging applications)
- ESLT +2.9% (awarded contracts from the Israel Ministry Of Defense in an aggregate material amount)
- OSG +2.9% (Director bought 40,000 shares at $4.73 - $4.78 worth ~$191K)
- ADBE +2.0% (Co. and Figma mutually agree to terminate merger agreement, originally announced on September 15, 2022)
- WWW +1.9% (advances transformation initiatives)
- SHEL +1.7% (files mixed shelf securities offering)
- ZWS +1.8% ( divests four wholly-owned subsidiaries that hold asbestos liabilities)
- OGN +1.8% (Co. and Eli Lilly (LLY) enter commercialization agreement in europe for two migraine medicines
- GSK +1.8% (Jemperli (dostarlimab) plus Zejula (niraparib) combination significantly improved progression-free survival in primary advanced or recurrent endometrial cancer in RUBY Part 2 Phase III trial)
Analyst comments:
- ALLK +6.7% (upgraded to Outperform from Mkt Perform at William Blair)
- EFX +5.0% ( upgraded to Buy from Hold at Jefferies; tgt raised to $315)
- EPR +3.5% (upgraded to Overweight from Neutral at JP Morgan; tgt $51)
- BNL +2.7% (upgraded to Overweight from Neutral at JP Morgan; tgt $19)
- CSIQ +1.7% (upgraded to Neutral from Sell at Goldman; tgt $25)
- ELME +1.6% (upgraded to Overweight from Neutral at JP Morgan; tgt raised to $18)